24/7 Market News Snapshot 16 October, 2025 – Femasys Inc. Common Stock (NASDAQ:FEMY)
DENVER, Colo., 16 October, 2025 (www.247marketnews.com) – (NASDAQ:FEMY) are discussed in this article.
Femasys Inc. has emerged as a focal point for investor interest today, as its stock (NASDAQ:FEMY) surged significantly, opening at $0.556 and peaking at $0.706, reflecting an impressive increase of 28.22%. Following a close of $0.551 yesterday, this notable rise underscores a robust bullish trend, with trading volume reaching 13.11 million shares. This momentum suggests a growing confidence among investors in Femasys’ innovative approaches within women’s reproductive health.
In tandem with this market activity, Femasys is set to showcase its pioneering work during the American Society for Reproductive Medicine (ASRM) 2025 Scientific Congress & Expo, held from October 25-29 at the Henry B. González Convention Center. Leading the company, CEO Kathy Lee-Sepsick, aims to highlight the FemaSeed® Intratubal Insemination technique—a groundbreaking artificial insemination solution that enhances the natural fertilization process by directly delivering sperm to the fallopian tubes, thereby significantly increasing conception probabilities.
The excitement surrounding this exhibition also revolves around FemaSeed’s affordability and less invasive nature compared to traditional intrauterine insemination (IUI). Recent clinical trials indicate that it has more than doubled pregnancy rates for individuals facing low male sperm counts. Femasys will also feature its complete suite of products, including the FemSperm™ Setup Kit, FemSperm Prep Kit, and FemSperm Analysis Kit, which empower gynecologists to conduct efficient sperm preparations within their practices.
As the ASRM Congress brings together over 5,500 professionals in reproductive medicine, Femasys invites attendees to engage in discussions about their transformative solutions aimed at improving accessibility and affordability in fertility care. The company continues its commitment to advancing women’s health through innovative in-office products and encourages interaction via social media platforms using the hashtag #ASRM2025. For more information on their offerings, Femasys points interested parties to their website.